Latest Breaking News On - Kaitlin gallagher - Page 1 : comparemela.com

Big day in Croke Park beckons for Na Fianna

AMO Pharma Announces Affirming Data from REACH-CDM Clinical Trial for AMO-02 in Treatment of Myotonic Dystrophy

Results to be reviewed during 2023 Myotonic Dystrophy Annual Conference show statistically and clinically significant efficacy benefits in multipl.

Nectero Medical Receives FDA Clearance of IND Application to Initiate Phase II/III Clinical Trial of Nectero EAST® System for Treatment of Small- to Mid-Sized Abdominal Aortic Aneurysms

/PRNewswire/ Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients lives,.

Recruiting U of A Employees 55-65 Years Old Who Wear Progressive Lenses When Using a Computer

Researchers are enrolling participants from the U of A community who are age 55-65 for a new study that will look at the use of large computer monitors.

Liminal BioSciences Inc.: Liminal BioSciences Provides R&D Update

LMNL6326 nominated as lead preclinical candidate for OXER1 antagonist development program, targeting the treatment of eosinophil-driven diseasesAdvancement of clinical trial application (CTA)